-
公开(公告)号:US20210053972A1
公开(公告)日:2021-02-25
申请号:US16963557
申请日:2019-01-23
Applicant: Bristol-Myers Squibb Company
Inventor: Kap-Sun YEUNG , Juliang ZHU , Paul Michael SCOLA
IPC: C07D471/10 , A61K31/438 , C07K14/705
Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
-
公开(公告)号:US20190185450A1
公开(公告)日:2019-06-20
申请号:US16315800
申请日:2017-07-05
Applicant: BRISTOL-MYERS SQUIBB COMPANY
Inventor: Kap-Sun YEUNG , Katharine A. Grant-Young , Juliang Zhu , Mark G. Saulnier , David B. Frennesson , Zhaoxing Meng , Paul Michael Scola
IPC: C07D401/10 , C07D413/14 , C07D417/14 , C07D417/12 , C07D405/14 , A61K45/06 , A61K31/4545 , A61K31/4439 , A61K31/498
Abstract: The present disclosure generally relates to compounds of formula (I), wherein R2 is a phenyl or pyridinyl moiety, useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
-
公开(公告)号:US20240124417A1
公开(公告)日:2024-04-18
申请号:US17766483
申请日:2020-10-01
Applicant: Bristol-Myers Squibb Company
Inventor: Kap-Sun YEUNG , Denis R. ST. LAURENT , Li-Qiang SUN , Zhiwei YIN , Katharine A. GRANT-YOUNG , Paul Michael SCOLA
IPC: C07D401/14 , A61K31/4439 , A61K31/4545 , A61K31/497 , A61K31/501 , A61K31/506 , C07D401/12 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D513/04
CPC classification number: C07D401/14 , A61K31/4439 , A61K31/4545 , A61K31/497 , A61K31/501 , A61K31/506 , C07D401/12 , C07D403/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D513/04
Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
-
公开(公告)号:US20210094932A1
公开(公告)日:2021-04-01
申请号:US16977374
申请日:2019-02-28
Applicant: Bristol-Myers Squibb Company
Inventor: Kap-Sun YEUNG , Denis R. ST. LAURENT , David R. LANGLEY , Paul Michael SCOLA
IPC: C07D401/12 , C07D401/14 , C07D213/85
Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
-
公开(公告)号:US20200181125A1
公开(公告)日:2020-06-11
申请号:US16499009
申请日:2018-03-26
Applicant: Bristol-Myers Squibb Company
Inventor: Kap-Sun YEUNG , Denis R. ST. LAURENT , Jeffrey Lee ROMINE , Paul Michael SCOLA
IPC: C07D405/14 , C07D405/12 , C07D401/14 , C07D401/12
Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various pp diseases, including cancer and infectious diseases. (I)
-
公开(公告)号:US20190352280A1
公开(公告)日:2019-11-21
申请号:US16471531
申请日:2017-12-19
Applicant: Bristol-Myers Squibb Company
Inventor: Kap-Sun YEUNG , Katharine A. GRANT-YOUNG , Li-Qiang SUN , David R. LANGLEY , Denis R. ST. LAURENT , Paul M. SCOLA
IPC: C07D401/14 , C07D471/08 , C07D413/14
Abstract: The present disclosure generally relates to compounds useful as immunomodulators. Provided herein are compounds, compositions comprising such compounds, and methods of their use. The disclosure further pertains to pharmaceutical compositions comprising at least one compound according to the disclosure that are useful for the treatment of various diseases, including cancer and infectious diseases.
-
-
-
-
-